{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T17:40:54Z","timestamp":1790876454765,"version":"4.1.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2021,3,29]],"date-time":"2021-03-29T00:00:00Z","timestamp":1616976000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,3,29]],"date-time":"2021-03-29T00:00:00Z","timestamp":1616976000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","award":["20K17467"],"award-info":[{"award-number":["20K17467"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharm Res"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1007\/s11095-021-03030-y","type":"journal-article","created":{"date-parts":[[2021,3,29]],"date-time":"2021-03-29T18:02:50Z","timestamp":1617040970000},"page":"637-646","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":76,"title":["Performance of Area under the Concentration-Time Curve Estimations of Vancomycin with Limited Sampling by a Newly Developed Web Application"],"prefix":"10.1007","volume":"38","author":[{"given":"Kazutaka","family":"Oda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumi","family":"Hashiguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshimi","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiro","family":"Tsuji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kensuke","family":"Shoji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiko","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuaki","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Kawamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideyuki","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshio","family":"Takesue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,3,29]]},"reference":[{"issue":"3","key":"3030_CR1","doi-asserted-by":"publisher","first-page":"e18","DOI":"10.1093\/cid\/ciq146","volume":"52","author":"C Liu","year":"2011","unstructured":"Liu C, Bayer A, Cosgrove SE, Daum RS, Fridkin SK, Gorwitz RJ, et al. J Rybak M, Talan DA, chambers HF; Infectious Diseases Society of America. Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children. Clin Infect Dis. 2011;52(3):e18\u201355. https:\/\/doi.org\/10.1093\/cid\/ciq146.","journal-title":"Clin Infect Dis"},{"issue":"3","key":"3030_CR2","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1007\/s10156-013-0599-4","volume":"19","author":"K Matsumoto","year":"2013","unstructured":"Matsumoto K, Takesue Y, Ohmagari N, Mochizuki T, Mikamo H, Seki M, et al. Practice guidelines for therapeutic drug monitoring of vancomycin: a consensus review of the Japanese Society of Chemotherapy and the Japanese Society of Therapeutic Drug Monitoring. J Infect Chemother. 2013;19(3):365\u201380. https:\/\/doi.org\/10.1007\/s10156-013-0599-4.","journal-title":"J Infect Chemother"},{"issue":"11","key":"3030_CR3","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1093\/ajhp\/zxaa036","volume":"77","author":"MJ Rybak","year":"2020","unstructured":"Rybak MJ, Le J, Lodise TP, Levine DP, Bradley JS, Liu C, et al. Therapeutic monitoring of vancomycin for serious methicillin-resistant Staphylococcus aureus infections: A revised consensus guideline and review by the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists. Am J Health Syst Pharm. 2020;77(11):835\u201364. https:\/\/doi.org\/10.1093\/ajhp\/zxaa036.","journal-title":"Am J Health Syst Pharm"},{"issue":"1","key":"3030_CR4","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1128\/AAC.01653-13","volume":"58","author":"MN Neely","year":"2014","unstructured":"Neely MN, Youn G, Jones B, Jelliffe RW, Drusano GL, Rodvold KA, et al. Are vancomycin trough concentrations adequate for optimal dosing? Antimicrob Agents Chemother. 2014;58(1):309\u201316. https:\/\/doi.org\/10.1128\/AAC.01653-13.","journal-title":"Antimicrob Agents Chemother"},{"issue":"12","key":"3030_CR5","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1002\/phar.2191","volume":"38","author":"RB Turner","year":"2018","unstructured":"Turner RB, Kojiro K, Shephard EA, Won R, Chang E, Chan D, et al. Review and validation of Bayesian dose-optimizing software and equations for calculation of the vancomycin area under the curve in critically ill patients. Pharmacotherapy. 2018;38(12):1174\u201383. https:\/\/doi.org\/10.1002\/phar.2191.","journal-title":"Pharmacotherapy."},{"key":"3030_CR6","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1093\/ajhp\/zxz070","volume":"76","author":"WD Kufel","year":"2019","unstructured":"Kufel WD, Seabury RW, Mogle BT, Beccari MV, Probst LA, Steele JM. Readiness to implement vancomycin monitoring based on area under the concentration-time curve: a cross-sectional survey of a national health consortium. Am J Health Syst Pharm. 2019;76:889\u201394. https:\/\/doi.org\/10.1093\/ajhp\/zxz070.","journal-title":"Am J Health Syst Pharm"},{"issue":"2","key":"3030_CR7","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1097\/00007691-199804000-00003","volume":"20","author":"M Yasuhara","year":"1998","unstructured":"Yasuhara M, Iga T, Zenda H, Okumura K, Oguma T, Yano Y, et al. Population pharmacokinetics of vancomycin in Japanese adult patients. Ther Drug Monit. 1998;20(2):139\u201348. https:\/\/doi.org\/10.1097\/00007691-199804000-00003.","journal-title":"Ther Drug Monit"},{"key":"3030_CR8","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/BF01404679","volume":"18","author":"KM Brown","year":"1972","unstructured":"Brown KM, Dennis JE. Derivative free analogues of the Levenberg\u2013Marquardt and gauss algorithms for nonlinear least square approximations. Numer Math. 1972;18:289\u201397. https:\/\/doi.org\/10.1007\/BF01404679.","journal-title":"Numer Math"},{"issue":"2","key":"3030_CR9","doi-asserted-by":"publisher","first-page":"210","DOI":"10.11250\/chemotherapy1953.40.210","volume":"40","author":"M Nakashima","year":"1992","unstructured":"Nakashima M, Katagiri K, Oguma T. Phase I studies on vancomycin hydrochloride for infection. Chemotherapy. 1992;40(2):210\u201324. https:\/\/doi.org\/10.11250\/chemotherapy1953.40.210.","journal-title":"Chemotherapy"},{"issue":"3","key":"3030_CR10","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1097\/FTD.0000000000000002","volume":"36","author":"K Oda","year":"2014","unstructured":"Oda K, Kasada T, Yoshikawa M, Tanoue M, Yamashita T, Takeshita Y. Therapeutic drug monitoring based on early measurements of serum teicoplanin levels in Japanese patients. Ther Drug Monit. 2014;36(3):401\u20135. https:\/\/doi.org\/10.1097\/FTD.0000000000000002.","journal-title":"Ther Drug Monit"},{"issue":"4","key":"3030_CR11","first-page":"587","volume":"77","author":"M Kobayashi","year":"2020","unstructured":"Kobayashi M, Kogure A, Uchiyama H, Tachiki H, Ueno K. A questionnaire evaluation of new vancomycin TDM software; TOWA-TDM (VCM). Igaku to Yakugaku. 2020;77(4):587\u201395.","journal-title":"Igaku to Yakugaku"},{"issue":"1","key":"3030_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5649\/jjphcs.34.1","volume":"34","author":"K Sano","year":"2008","unstructured":"Sano K, Suzuki N, Saitoh M. Performance of various pharmacokinetic parameters in predicting vancomycin serum concentrations. Jpn J Pharm Health Care Sci. 2008;34(1):1\u201312. https:\/\/doi.org\/10.5649\/jjphcs.34.1.","journal-title":"Jpn J Pharm Health Care Sci"},{"issue":"9","key":"3030_CR13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0203453","volume":"13","author":"A Komoto","year":"2018","unstructured":"Komoto A, Maiguma T, Teshima D, Sugiyama T, Haruki Y. Effects of pharmacist intervention in vancomycin treatment for patients with bacteremia due to methicillin-resistant Staphylococcus aureus. PLoS One. 2018;13(9):e0203453. https:\/\/doi.org\/10.1371\/journal.pone.0203453.","journal-title":"PLoS One"},{"issue":"10","key":"3030_CR14","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.11250\/chemotherapy1953.41.1079","volume":"41","author":"T Takenaka","year":"1993","unstructured":"Takenaka T, Watanabe T, Hayashi T, Hata K, Ono N, Kumon H, et al. Pharmacokinetics of vancomycin and dosage planning in patients with renal insufficiency. Chemotherapy. 1993;41(10):1079\u201389. https:\/\/doi.org\/10.11250\/chemotherapy1953.41.1079.","journal-title":"Chemotherapy"},{"issue":"1","key":"3030_CR15","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1159\/000180580","volume":"16","author":"DW Cockcroft","year":"1976","unstructured":"Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16(1):31\u201341. https:\/\/doi.org\/10.1159\/000180580.","journal-title":"Nephron."},{"issue":"2","key":"3030_CR16","doi-asserted-by":"publisher","first-page":"e02042","DOI":"10.1128\/AAC.02042-17","volume":"62","author":"MN Neely","year":"2018","unstructured":"Neely MN, Kato L, Youn G, Kraler L, Bayard D, van Guilder M, et al. Prospective trial on the use of trough concentration versus area under the curve to determine therapeutic vancomycin dosing. Antimicrob Agents Chemother. 2018;62(2):e02042\u201317. https:\/\/doi.org\/10.1128\/AAC.02042-17.","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"3030_CR17","doi-asserted-by":"publisher","first-page":"106109","DOI":"10.1016\/j.ijantimicag.2020.106109","volume":"56","author":"K Oda","year":"2020","unstructured":"Oda K, Jono H, Nosaka K, Saito H. Reduced nephrotoxicity with vancomycin therapeutic drug monitoring guided by area under the concentration-time curve against a trough 15\u201320 \u03bcg\/mL concentration. Int J Antimicrob Agents. 2020;56(4):106109. https:\/\/doi.org\/10.1016\/j.ijantimicag.2020.106109.","journal-title":"Int J Antimicrob Agents"},{"issue":"4","key":"3030_CR18","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1002\/phar.2234","volume":"39","author":"L Meng","year":"2019","unstructured":"Meng L, Wong T, Huang S, Mui E, Nguyen V, Espinosa G, et al. Conversion from vancomycin trough concentration-guided dosing to area under the curve-guided dosing using two sample measurements in adults: implementation at an academic medical center. Pharmacotherapy. 2019;39(4):433\u201342. https:\/\/doi.org\/10.1002\/phar.2234.","journal-title":"Pharmacotherapy."},{"issue":"12","key":"3030_CR19","doi-asserted-by":"publisher","first-page":"e01293","DOI":"10.1128\/AAC.01293-17","volume":"61","author":"NA Finch","year":"2017","unstructured":"Finch NA, Zasowski EJ, Murray KP, Mynatt RP, Zhao JJ, Yost R, et al. A quasi-experiment to study the impact of vancomycin area under the concentration-time curve-guided dosing on vancomycin-associated nephrotoxicity. Antimicrob Agents Chemother. 2017;61(12):e01293\u201317. https:\/\/doi.org\/10.1128\/AAC.01293-17.","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"3030_CR20","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1159\/00034316","volume":"58","author":"Y Suzuki","year":"2012","unstructured":"Suzuki Y, Kawasaki K, Sato Y, Tokimatsu I, Itoh H, Hiramatsu K, et al. Is peak concentration needed in therapeutic drug monitoring of vancomycin? A pharmacokinetic-pharmacodynamic analysis in patients with methicillin-resistant Staphylococcus aureus pneumonia. Chemotherapy. 2012;58(4):308\u201312. https:\/\/doi.org\/10.1159\/00034316.","journal-title":"Chemotherapy."},{"issue":"1","key":"3030_CR21","doi-asserted-by":"publisher","first-page":"e0146224","DOI":"10.1371\/journal.pone.0146224","volume":"11","author":"P Men","year":"2016","unstructured":"Men P, Li HB, Zhai SD, Zhao RS. Association between the AUC0\u201324\/MIC ratio of vancomycin and its clinical effectiveness: A systematic review and meta-analysis. PLoS One. 2016;11(1):e0146224. https:\/\/doi.org\/10.1371\/journal.pone.0146224.","journal-title":"PLoS One"},{"issue":"4","key":"3030_CR22","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1097\/FTD.0000000000000622","volume":"41","author":"L Clark","year":"2019","unstructured":"Clark L, Skrupky LP, Servais R, Brummitt CF, Dilworth TJ. Examining the relationship between vancomycin area under the concentration-time curve and serum trough levels in adults with presumed or documented staphylococcal infections. Ther Drug Monit. 2019;41(4):483\u20138. https:\/\/doi.org\/10.1097\/FTD.0000000000000622.","journal-title":"Ther Drug Monit"},{"issue":"11","key":"3030_CR23","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1248\/bpb1978.4.879","volume":"4","author":"K Yamaoka","year":"1981","unstructured":"Yamaoka K, Tanigawara Y, Nakagawa T, Uno T. A pharmacokinetic analysis program (multi) for microcomputer. Aust J Pharm. 1981;4(11):879\u201385. https:\/\/doi.org\/10.1248\/bpb1978.4.879.","journal-title":"Aust J Pharm"},{"key":"3030_CR24","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1146\/annurev.me.39.020188.002341","volume":"39","author":"AS Levey","year":"1988","unstructured":"Levey AS, Perrone RD, Madias NE. Serum creatinine and renal function. Annu Rev Med. 1988;39:465\u201390. https:\/\/doi.org\/10.1146\/annurev.me.39.020188.002341.","journal-title":"Annu Rev Med"},{"issue":"2","key":"3030_CR25","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1097\/FTD.0b013e31803bcfd2","volume":"29","author":"A Tanaka","year":"2007","unstructured":"Tanaka A, Suemaru K, Otsuka T, Ido K, Nishimiya T, Sakai I, et al. Estimation of the initial dose setting of vancomycin therapy with use of cystatin C as a new marker of renal function. Ther Drug Monit. 2007;29(2):261\u20134. https:\/\/doi.org\/10.1097\/FTD.0b013e31803bcfd2.","journal-title":"Ther Drug Monit"}],"container-title":["Pharmaceutical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-021-03030-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11095-021-03030-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-021-03030-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,20]],"date-time":"2021-04-20T19:37:50Z","timestamp":1618947470000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11095-021-03030-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,29]]},"references-count":25,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["3030"],"URL":"https:\/\/doi.org\/10.1007\/s11095-021-03030-y","relation":{},"ISSN":["0724-8741","1573-904X"],"issn-type":[{"value":"0724-8741","type":"print"},{"value":"1573-904X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,29]]},"assertion":[{"value":"31 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 March 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}